Cite
HARVARD Citation
Guo, J. et al. (2023). Reversing the negative effect of adenosine A1 receptor-targeted immunometabolism modulation on melanoma by a co-delivery nanomedicine for self-activation of anti-PD-L1 DNAzyme. Nano today. p. . [Online].